Can we reach UNAIDS 90-90- 90 targets and will this lead to the elimination of HIV in the UK? Dr Valerie Delpech Head of national HIV surveillance.

Slides:



Advertisements
Similar presentations
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
Advertisements

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
HIV Self-Sampling: Establishing a sustainable service
Treatment as prevention: cannot succeed without increased testing AND PRIMARY PREVENTION example from the United Kingdom? Dr Valerie Delpech Head of HIV.
HIV in the United Kingdom: Setting the scene
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
EIIHA Pilot Projects PROVIDING GUIDANCE FOR EARLY IDENTIFICATION, ENHANCE TESTING, AND FAST TRACKING TO CARE.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Australia’s domestic HIV Strategy: 2014 and beyond Professor Chris Baggoley Chief Medical Officer Australian Government Department of.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
Late HIV Diagnoses, Georgia,
DR. LAURIE DILL, M.D. MEDICAL DIRECTOR, MEDICAL AIDS OUTREACH OF ALABAMA The President’s Advisory Council on HIV/AIDS February 28, 2012 Access to Care.
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
HIV Self-Sampling Dr Michael Brady Medical Director, Terrence Higgins Trust Dr Alan McOwan HIV and Sexual Health Consultant, 56 Dean Street Chelsea and.
“Writing our own narratives” The Global Advocacy Agenda for Young People Living with HIV.
Testing history and risk behaviour of individuals requesting an HIV test through an online self-sampling service SJ Westrop 1, C James.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
Testing times: Home testing and testing initiatives in Sexual Health & HIV Dr Michael Brady Medical Director, Terrence Higgins Trust Consultant, Sexual.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Division of HIV/AIDS Prevention CDC-RFA-PS
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
The Minority AIDS Initiative (MAI): Then and Now Edwin M. Craft, Dr. P
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
Sexual transmission of HIV amongst migrant populations in Europe: managing change in surveillance, interventions and prevention V.Delpech and Teymur Noori.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Treatment as Prevention and Treatment 2.0 Update UN Forum on AIDS, 24 June 2011 Nicole Seguy, Zhang Lan, WHO.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Martin Fisher Foundation: 14 September Remembering Martin Fisher Simon Collins, HIV i-Base Who should get tested? How and why should.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
CEO Report 2015 Positive Life NSW Annual General Meeting 7 December 2015 Craig Cooper.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia Last updated: December 2014.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
HIV in America What’s New in 2012 Christopher Hurt, MD Clinical Assistant Professor NC AIDS Education and Training Center 2012 HIV Update.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Understanding HIV risk and transmission among migrants
HIV self-testing: feasibility and acceptability of a large scale national service Cary James Head of Health Improvement Programmes Terrence Higgins Trust,
How differentiated care supports “Tx all” and Dr
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Continuum of HIV Care, Treatment, and Prevention
HIV testing guidance: know, treat, prevent
HIV Care Continuum in Manhattan
Providing Guidance For Early Identification, Enhance Testing, and Fast Tracking to Care EIIHA Pilot Projects.
Daniel Simões HIV in Europe Portugal
Overview of importance and emerging innovations for testing and linkage CHERYL JOHNSON WORLD HEALTH ORGANIZATION HIV AND HEPATITIS DEPARTMENT 23 JULY.
Brief overview of HIV among MSM in the EU/EEA
Migrants Dr Julia del Amo National Center for Epidemiology
Blood borne viral hepatitis action in Wales
HIV.
HIV in Minnesota: Challenges and Opportunities
Lesson 3: Treatment as Prevention
Presentation transcript:

Can we reach UNAIDS targets and will this lead to the elimination of HIV in the UK? Dr Valerie Delpech Head of national HIV surveillance

Contents of today’s talk Highlights from our annual report 2014  All of the information is in on the PHE website somewhere UNAIDS targets 2

HIV in the United Kingdom

People living with HIV in the UK in 2013 HIV diagnoses, AIDS & deaths 6,000 new HIV diagnoses 42% diagnosed late 319 reports of AIDS 577 all cause deaths Accessing HIV care 81,512 living with diagnosed HIV infection 87% receiving ART of whom 95% virally suppressed Total living with HIV ( ,800) PLHIV (20,300-33,800) unaware

People living with HIV Diagnosed and undiagnosed

People accessing HIV care

New diagnoses

16 New HIV diagnoses and number of persons accessing HIV care in the United Kingdom: 2014

18

19 New HIV diagnoses and number of persons accessing HIV care in the United Kingdom: 2014

Late diagnosis & deaths

Number of new HIV diagnoses Proportion with CD4 <350 cells, UK

MSM with diagnosed HIV, United Kingdom 24

HIV Testing

Self-reported high risk sexual behaviour among MSM by HIV status, GMSHS (2 nd July 2013)

HIV tests ordered on-line 4 th generation dried blood spot 3 rd generation oral swab Samples posted to laboratory Individual informed of result Negatives by text Positives by phone and letter Referral to HIV service recommended HIV Self-Sampling Services

Results from 2 nd phase support  5 months of operation (Nov 13 – March 14), these two services have delivered: −12,485 test requests −6,593 returned (53%) −92 new diagnoses (1.4% positivity)  Major issues highlighted from pilot phases −High volumes that can be managed through the internet −Different to clinic populations (younger and more rural) −Used by those at high risk due to testing and sexual behaviour −Good linkage to care −High user satisfaction 31

Self-reported HIV testing history 32 n= % 41% 25% MSM Black African Heterosexuals

Self-reported HIV testing behaviour among MSM, GMSHS (2 nd July 2013)

Quality of HIV care - late diagnosis - link to care - one year mortality post diagnosis

Positive Voices Study – Preliminary results (n=700 PLHIV in the UK)

Link to care: proportion* of adults with a CD4 count within 1 and 3 months of diagnosis: UK, 2013

Continuum of care Reaching

UNAIDS targets by % PLHIV know their status 90% of diagnosed on sustainable ART 90% of treated have a durable viral suppression  ‘ This would result in the end of AIDS and make HIV transmission rare by 2030’

Are the UNAIDS goals achievable? And if they were would it result in the end of AIDS? and a near elimination of HIV? 43

Treatment as Prevention Granich RM et al, Lancet 2009; 373: 48– 57 MTCT and breastfeeding Cohort of couples Swiss statement Ecological RCT HPTN052 Modelling PARTNER study Real world (26%-96%)

People in HIV care in Presentation title - edit in Header and Footer 81,512 living with diagnosed HIV infection 97% linked to care within 3 months >95% retained in care annually 92% in need of treatment are on treatment (87% of all diagnosed) 95% on treatment achieve VL<200 copies/ml

46 Presentation title - edit in Header and Footer Continuum of Care People living with HIV, United Kingdom, 2013

Estimated number persons living with HIV infection (diagnosed and undiagnosed), UK

People living with HIV by diagnostic and treatment status, and number with detectable viral load, UK,

Phillips et al – Plos One 2013 Incidence of HIV per 100 MSM-year, UK

Counter – factual scenario No condom use Phillips et al PLOS One 2013 No condom use (a)ART at diagnosis from 2000 (A) Cessation of all condoms in 2000 would have resulted in a 400% increase in incidence

Increased testing Uptake of TasP 52

ECDC. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; Availability of ART for undocumented migrants 2012

Proportion of patients with VL <200 copies 12 months after ART initiation, by CD4 at ART start, UK

Proportion MSM in the UK Potential increases in testing: probability of diagnosis by time from infection, Phillips, PLOS One 2014 Years from infection base test rate (Current situation) test rate + test rate ++

Number of new infections per year Year HIV incidence among MSM, Phillips PLOS One 2014 test rate ++ ART 350 base test rate ART at diagnosis test rate + ART at diagnosis test rate ++ ART at diagnosis test rate + ART at 350 base test rate ART at % CI given for two lines to illustrate uncertainty over mean effect

High HIV transmission among MSM in the UK Role primary infection likely to be substantive 30%- 60% of all infections Testing rates remain too low High rates of STIs and other co-infections Condom uptake remains too low – serosorting is not safe Changing social networks with wide use of apps to find casual partners Increase in chemsex Failure of partner notification policies Low uptake of TasP 58

Whole system approach

Promote sexual health among LGBT communities across the lifecourse Tackling homophobia and bullying Education in Schools Increase use of high-quality, coordinated educational, clinical, and other preventive services Increase knowledge, communication, and respectful attitudes regarding sexual health and drug and alcohol use Promoting opportunities to discuss role of pleasure, satisfaction and ability to use drugs with the least harm Increase healthy, responsible, and respectful sexual behaviors and relationships Decrease adverse health outcomes, including HIV/STDs, viral hepatitis, and sexual violence 60 Source: Douglas JM Jr, Fenton KA. Public Health Rep Mar-Apr;128 Suppl 1:1-4

Community engagement Stigma and discrimination remains major barrier to testing, link and retention in care and prevention efforts Need greater engagement of PLHIV and affected communities at every level Tailored messages for individuals recognising diverse nature of community Supporting peer-led initiatives and outreach programs Sustained funding for NGOs Provision of integrated and welcoming, non judging services in partnership with NGOs 61Presentation title - edit in Header and Footer

Conclusions 62

Conclusions HIV epidemic is contained in the United Kingdom Reaching may be possible Whole system approach is required with greater investment in primary prevention Expand and target testing with novel diagnostics must be scale up. Greater emphasis on combination of identifying persons in primary infection+ early treatment/TasP + intense partner notification The challenge is identifying persons in early infection (eg recall of high risk STI attendees, home sampling and testing, use of apps etc) Prevention strategies including condom use, PREP, reduced partners, treatment of STIs, and improvements in sexual wellbeing, mental health and non-harmful use of drugs and alcohol remain critical in the control of HIV and other STIs epidemic. Greater engagement and involvement of community at all levels 66 Presentation title - edit in Header and Footer